fbpx
Menu

Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA

Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA

Dr. Alexandros Marios Sofias, RWTH Aachen University, Germany

This webinar describes a multiscale and multimodal optical imaging approach for evaluating core-crosslinked polymeric micelles (CCPM) designed for cancer treatment. The biodistribution and target site accumulation of CCPM were macroscopically and microscopically investigated. To this end, fluorophore-labeled CCPM were intravenously injected in mice bearing 4T1 triple-negative breast cancer (TNBC) tumors, and their localization at the whole-body, tissue and cellular level was analyzed using multimodal and multiscale optical imaging. At the organism level, a non-invasive 3D micro-computed tomography-fluorescence tomography (μCT-FLT) and 2D fluorescence reflectance imaging (FRI) was performed. At the tissue and cellular level, extensive immunohistochemistry, focusing primarily on cancer, endothelial and phagocytic immune cells was performed.

Took place: November, 2020

CT Optical
LinkedinWhatsApp
Back to all webinars

You may also like

Multimodal in vivo imaging of CAR T cell therapies using MILab’s OI-CT system
Multimodal in vivo imaging of CAR T cell therapies using MILab’s OI-CT system
This webinar describes Miltenyi Biotech’s approach establishing multimodal optical imaging of CAR T cell therapies, using the MILabs optical imaging micro CT system.
CT Optical
Multiscale optical imaging for unraveling the in vivo fate of nanomedicine
Multiscale optical imaging for unraveling the in vivo fate of nanomedicine
The Institute for Experimental Molecular Imaging’s (RWTH Aachen) research team uses MILabs Optical imaging system, intravital microscopy, and immunohistochemistry to investigate cancer nanomedicine delivery and uptake in vivo.
CT Optical
Dual Isotope Imaging Using the MILabs VECTorCT: Applications in Oncology
Dual Isotope Imaging Using the MILabs VECTorCT: Applications in Oncology
This webinar covers some recent groundbreaking studies conducted by the Cornelissen group in Oxford. Several recent papers will be presented including ‘Early detection in a mouse model of pancreatic cancer by imaging DNA damage response signaling’, ‘Dual-isotope antibody imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours’, and ‘Imaging DNA Damage Repair in vivo Following 177Lu-DOTATATE Therapy’.
CT PET SPECT

Global Sales, Service & Support

Duwboot 7a
3991 CD  Houten
The Netherlands

Phone: +31 88 756 5343
Fax: +31 88 756 0094
E-mail: [email protected]
REQUEST MORE INFORMATION

Distributors

MILabs products are used in more than 65 countries and are supported by a global network of distributors and factory trained support engineers.

Please contact MILabs directly for more information about your local MILabs business partner.

Scroll to Top